Literature DB >> 18797300

Hypothalamic-pituitary-adrenal axis disregulation in PrPC-null mice.

Manuel Sanchez-Alavez1, José R Criado, Izabella Klein, Gianluca Moroncini, Bruno Conti.   

Abstract

As manifestations of prion diseases include disturbances of hypothalamic and pituitary functions, we tested the hypothesis that the cellular prion protein (PrPC) has a role as modulator of the hypothalamic-pituitary-adrenal axis. The level of corticosterone and adrenocorticotropic hormone were compared in PrPC null (PrP 0/0) and wild-type (PrP+/+) mice. PrP 0/0 showed hypercorticism during the dark part of day. After acute stress, corticosterone and adrenocorticotropic hormone increased similarly in PrP+/+ and PrP 0/0 mice. Adrenocorticotropic hormone, however, remained elevated in PrP+/+ 0/0 mice at corticosterone levels that are inhibitory in PrP mice. Pretreatment with corticosterone or dexamethasone inhibited stress-induced elevation of adrenocorticotropic hormone in PrP+/+ but not in PrP 0/0 mice. Thus, PrPC may play a role in the negative feedback regulation of axis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18797300      PMCID: PMC2649708          DOI: 10.1097/WNR.0b013e32830f1e90

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  24 in total

Review 1.  The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis.

Authors:  L Jacobson; R Sapolsky
Journal:  Endocr Rev       Date:  1991-05       Impact factor: 19.871

2.  Pancreatic lesions and hypoglycemia-hyperinsulinemia in scrapie-injected hamsters.

Authors:  R I Carp; Y S Kim; S M Callahan
Journal:  J Infect Dis       Date:  1990-03       Impact factor: 5.226

3.  Corticoid concentrations are increased in the plasma and urine of ewes with naturally occurring scrapie.

Authors:  F Schelcher; N Picard-Hagen; V Laroute; V Gayrard; M A Popot; O Andreoletti; P L Toutain
Journal:  Endocrinology       Date:  1999-05       Impact factor: 4.736

4.  PrP gene dosage and long term potentiation.

Authors:  J C Manson; J Hope; A R Clarke; A Johnston; C Black; N MacLeod
Journal:  Neurodegeneration       Date:  1995-03

Review 5.  Corticosteroid inhibition of ACTH secretion.

Authors:  M E Keller-Wood; M F Dallman
Journal:  Endocr Rev       Date:  1984       Impact factor: 19.871

6.  Diurnal blood pressure variation and hormonal correlates in fatal familial insomnia.

Authors:  F Portaluppi; P Cortelli; P Avoni; L Vergnani; M Contin; P Maltoni; A Pavani; E Sforza; E C degli Uberti; P Gambetti
Journal:  Hypertension       Date:  1994-05       Impact factor: 10.190

7.  The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress.

Authors:  D Diorio; V Viau; M J Meaney
Journal:  J Neurosci       Date:  1993-09       Impact factor: 6.167

8.  129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal.

Authors:  J C Manson; A R Clarke; M L Hooper; L Aitchison; I McConnell; J Hope
Journal:  Mol Neurobiol       Date:  1994 Apr-Jun       Impact factor: 5.590

9.  Normal host prion protein necessary for scrapie-induced neurotoxicity.

Authors:  S Brandner; S Isenmann; A Raeber; M Fischer; A Sailer; Y Kobayashi; S Marino; C Weissmann; A Aguzzi
Journal:  Nature       Date:  1996-01-25       Impact factor: 49.962

10.  Hemorrhage-induced secretion of corticotropin-releasing factor-like immunoreactivity into the rat hypophysial portal circulation and its inhibition by glucocorticoids.

Authors:  P M Plotsky; W Vale
Journal:  Endocrinology       Date:  1984-01       Impact factor: 4.736

View more
  2 in total

1.  Behavioral abnormalities in prion protein knockout mice and the potential relevance of PrP(C) for the cytoskeleton.

Authors:  Matthias Schmitz; Saima Zafar; Christopher J Silva; Inga Zerr
Journal:  Prion       Date:  2014       Impact factor: 3.931

Review 2.  To develop with or without the prion protein.

Authors:  Sophie Halliez; Bruno Passet; Séverine Martin-Lannerée; Julia Hernandez-Rapp; Hubert Laude; Sophie Mouillet-Richard; Jean-Luc Vilotte; Vincent Béringue
Journal:  Front Cell Dev Biol       Date:  2014-10-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.